1131871-56-1

Basic information

• Product Name: [(S)-2-(3,3-difluoropyrrolidin-1-yl)-1-(2-fluoro-4-{3-[1-(3-isopropyl-[1,2,4]oxadiazol-5-yl)piperidin-4-yl]propoxy}benzyl)-2-oxoethyl]carbamic acid tert-butyl ester
• Synonyms: [(S)-2-(3,3-difluoropyrrolidin-1-yl)-1-(2-fluoro-4-{3-[1-(3-isopropyl-[1,2,4]oxadiazol-5-yl)piperidin-4-yl]propoxy}benzyl)-2-oxoethyl]carbamic acid tert-butyl ester
• CAS NO: 1131871-56-1
• Molecular Weight: 623.716
• Mol File: 1131871-56-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: [(S)-2-(3,3-difluoropyrrolidin-1-yl)-1-(2-fluoro-4-{3-[1-(3-isopropyl-[1,2,4]oxadiazol-5-yl)piperidin-4-yl]propoxy}benzyl)-2-oxoethyl]carbamic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: [(S)-2-(3,3-difluoropyrrolidin-1-yl)-1-(2-fluoro-4-{3-[1-(3-isopropyl-[1,2,4]oxadiazol-5-yl)piperidin-4-yl]propoxy}benzyl)-2-oxoethyl]carbamic acid tert-butyl ester(1131871-56-1)
• EPA Substance Registry System: [(S)-2-(3,3-difluoropyrrolidin-1-yl)-1-(2-fluoro-4-{3-[1-(3-isopropyl-[1,2,4]oxadiazol-5-yl)piperidin-4-yl]propoxy}benzyl)-2-oxoethyl]carbamic acid tert-butyl ester(1131871-56-1)

Safety Data

• Hazardous Substances Data: 1131871-56-1(Hazardous Substances Data)

Upstream product

• 1131871-54-9 (S)-2-tert-butoxycarbonylamino-3-(2-fluoro-4-{3-[1-(3-isopropyl-[1,2,4]oxadiazol-5-yl)piperidin-4-yl]propoxy}phenyl)propionic acid 
• 163457-23-6 3,3-difluoropyrrolidine hydrochloride 

Relevant articles and documents

COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS

The present invention is directed to therapeutic compounds which have dual activity as agonists of GPR119 and inhibitors of DPP-IV and are useful for the treatment of metabolic disorders including type II diabetes.